BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34830137)

  • 21. Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1.
    Fischer T; Doll C; Jacobs S; Kolodziej A; Stumm R; Schulz S
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4519-24. PubMed ID: 18697876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors.
    Schmid HA; Lambertini C; van Vugt HH; Barzaghi-Rinaudo P; Schäfer J; Hillenbrand R; Sailer AW; Kaufmann M; Nuciforo P
    Neuroendocrinology; 2012; 95(3):232-47. PubMed ID: 22156600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follicle-stimulating hormone receptors: A comparison of commercially-available monoclonal and polyclonal antibodies as immunohistochemical markers for cancer research.
    Bonci EA; Buiga R; Badan M; Iuliana Maja L; Gata VA; Lisencu IC; Irimie A; Achimas Cadariu P; Piciu D
    J BUON; 2018; 23(6):1912-1921. PubMed ID: 30610821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the chemokine receptor CXCR2 in normal and neoplastic neuroendocrine cells.
    Tecimer T; Dlott J; Chuntharapai A; Martin AW; Peiper SC
    Arch Pathol Lab Med; 2000 Apr; 124(4):520-5. PubMed ID: 10747307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reassessment of sst(5) somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-4.
    Lupp A; Hunder A; Petrich A; Nagel F; Doll C; Schulz S
    Neuroendocrinology; 2011; 94(3):255-64. PubMed ID: 21952553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A; Zabel M; Biczysko W
    Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours.
    Milner R; Wombwell H; Eckersley S; Barnes D; Warwicker J; Van Dorp E; Rowlinson R; Dearden S; Hughes G; Harbron C; Wellings B; Hodgson D; Womack C; Gray N; Lau A; O'Connor MJ; Marsden C; Kvist AJ
    Virchows Arch; 2013 Mar; 462(3):269-79. PubMed ID: 23354597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VPAC2 receptor expression in human normal and neoplastic tissues: evaluation of the novel MAB SP235.
    Schulz S; Mann A; Novakhov B; Piggins HD; Lupp A
    Endocr Connect; 2015 Mar; 4(1):18-26. PubMed ID: 25504760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.
    Nekulova M; Holcakova J; Nenutil R; Stratmann R; Bouchalova P; Müller P; Mouková L; Coates PJ; Vojtesek B
    Virchows Arch; 2013 Sep; 463(3):415-25. PubMed ID: 23887585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues.
    Ginn PE
    Vet Pathol; 1996 Sep; 33(5):533-41. PubMed ID: 8885180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker.
    Ivanova A; Liao SY; Lerman MI; Ivanov S; Stanbridge EJ
    J Med Genet; 2005 Jul; 42(7):565-76. PubMed ID: 15994878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel monoclonal antibodies detect Smad-interacting protein 1 (SIP1) in the cytoplasm of human cells from multiple tumor tissue arrays.
    Oztas E; Avci ME; Ozcan A; Sayan AE; Tulchinsky E; Yagci T
    Exp Mol Pathol; 2010 Oct; 89(2):182-9. PubMed ID: 20515682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples.
    Agostinelli C; Sabattini E; Gjørret JO; Righi S; Rossi M; Mancini M; Piccaluga PP; Bacci F; Marafioti T; Bettini G; Falini B; Pileri SA
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):561-72. PubMed ID: 20697266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropeptide S receptor 1 (NPSR1) activates cancer-related pathways and is widely expressed in neuroendocrine tumors.
    Pulkkinen V; Ezer S; Sundman L; Hagström J; Remes S; Söderhäll C; Greco D; Haglund C; Kere J; Arola J
    Virchows Arch; 2014 Aug; 465(2):173-83. PubMed ID: 24915894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44 isoform expression in the diffuse neuroendocrine system. II. Benign and malignant tumors.
    Komminoth P; Seelentag WK; Saremaslani P; Heitz PU; Roth J
    Histochem Cell Biol; 1996 Dec; 106(6):551-62. PubMed ID: 8985743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2.
    Fischer T; Nagel F; Jacobs S; Stumm R; Schulz S
    PLoS One; 2008; 3(12):e4069. PubMed ID: 19116653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Finding of Paired Box 5 (PAX5) Cytoplasmic Staining in Well-differentiated Rectal Neuroendocrine Tumors (Carcinoids) and Its Diagnostic and Potentially Prognostic Utility.
    Fu Z; Zuo C; Sheehan CE; Patil DT; Lin J; Yang Z; Lee H
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):454-460. PubMed ID: 29561272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.
    Uccella S; La Rosa S; Volante M; Papotti M
    Endocr Pathol; 2018 Jun; 29(2):150-168. PubMed ID: 29520563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syntaxin 1: A Novel Robust Immunophenotypic Marker of Neuroendocrine Tumors.
    Kővári B; Turkevi-Nagy S; Báthori Á; Fekete Z; Krenács L
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.